Koninklijke Philips NV
PHIA: XAMS (NLD)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€26.00 | Xplh | Jmklt |
Philips' Diagnostic Imaging Business on the Path to Growth
Business Strategy and Outlook
Philips is one of the leaders in imaging and image-guided therapies. But the company's track record is checkered, with multiple self-induced missteps tarnishing its reputation and investor confidence. We believe the resolution of sleep care problems, focus on its high-performing areas, and new management team should be able change the narrative, but uncertainty remains.